Rolipram impairs NF-κB activity and MMP-9 expression in experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 168, Issue 1-2, 2005, Pages 13-20

  Sánchez, Antonio J ^a   Puerta, Carmen ^a   Ballester, Sara ^b   González, Paz ^a   Arriaga, Angel ^a   García Merino, Antonio ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Experimental autoimmune encephalomyelitis; Matrix metalloproteinase 9; Nuclear factor kappa B; Rolipram

Indexed keywords

CD3 ANTIGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MYELIN BASIC PROTEIN; ROLIPRAM;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BINDING SITE; CELL INFILTRATION; CELL LINE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; LYMPH NODE CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; SPINAL CORD;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; LUCIFERASES; LYMPH NODES; LYMPHOCYTES; MATRIX METALLOPROTEINASE 9; MYELIN BASIC PROTEINS; NF-KAPPA B; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROLIPRAM; SPINAL CORD; TRANSFECTION;

EID: 25844519171     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.03.024     Document Type: Article

References (39)

1. N. Abbas, L.P. Zou, S.H. Pelidou, B. Winblad, and J. Zhu Protective effect of rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system Autoimmunity 32 2000 93 99
2. D. Agnello, L. Carvelli, V. Muzio, P. Villa, B. Bottazzi, N. Polentarutti, T. Mennini, A. Mantovani, and P. Ghezzi Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram J. Neuroimmunol. 109 2000 105 111
3. N. Arima, W.A. Kuziel, T.A. Grdina, and W.C. Greene IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression J. Immunol. 149 1992 83 91
4. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K., 1992. In Short Protocols in Molecular Biology. Harvard Medical School, John Wiley and Sons, New York, 2nd edition, pp. 2-24.
5. M. Bond, R.P. Fabunmi, A.H. Baker, and A.C. Newby Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B FEBS Lett. 435 1998 29 34
6. J.R. Burke Targeting I kappa B kinase for the treatment of inflammatory and other disorders Curr. Opin. Drug Discov. Dev. 6 2003 720 728
7. S. Curran, and G.I. Murray Matrix metalloproteinases in tumour invasion and metastasis J. Pathol. 189 1999 300 308
8. B. Dorado, P. Portoles, and S. Ballester NF-kappaB in Th2 cells: delayed and long-lasting induction through the TCR complex Eur. J. Immunol. 28 1998 2234 2244
9. C. Du, J.J. Bright, and S. Sriram Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice J. Neuroimmunol. 114 2001 69 79
10. C. Du, M.W. Khalil, and S. Sriram Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice J. Immunol. 167 2001 7094 7101
11. W. Eberhardt, A. Huwiler, K.F. Beck, S. Walpen, and J. Pfeilschifter Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways J. Immunol. 165 2000 5788 5797
12. C.P. Genain, T. Roberts, R.L. Davis, M.H. Nguyen, A. Uccelli, D. Faulds, Y. Li, J. Hedgpeth, and S.L. Hauser Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor Proc. Natl. Acad. Sci. U. S. A. 92 1995 3601 3605
13. K. Gijbels, S. Masure, H. Carton, and G. Opdenakker Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders J. Neuroimmunol. 41 1992 29 34
14. K. Gijbels, R.E. Galardy, and L. Steinman Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases J. Clin. Invest. 94 1994 2177 2182
15. Y.P. Han, T.L. Tuan, M. Hughes, H. Wu, and W.L. Garner Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin J. Biol. Chem. 276 2001 22341 22350
16. H.P. Hartung, and B.C. Kieseier The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system J. Neuroimmunol. 107 2000 140 147
17. M.T. Heneka, A. Sharp, P. Murphy, J.A. Lyons, L. Dumitrescu, and D.L. Feinstein The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice J. Neurochem. 77 2001 568 579
18. B. Hilliard, E.B. Samoilova, T.S. Liu, A. Rostami, and Y. Chen Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: roles of NF-kappa B in the activation and differentiation of autoreactive T cells J. Immunol. 163 1999 2937 2943
19. M. Ichimura, and H. Kase A new cyclic nucleotide phosphodiesterase isozyme expressed in the T-lymphocyte cell lines Biochem. Biophys. Res. Commun. 193 1993 985 990
20. J.L. Jimenez, C. Punzon, J. Navarro, M.A. Munoz-Fernandez, and M. Fresno Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation J. Pharmacol. Exp. Ther. 299 2001 753 759
21. C. Kaltschmidt, B. Kaltschmidt, J. Lannes-Vieira, G.W. Kreutzberg, H. Wekerle, P.A. Baeuerle, and J. Gehrmann Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis J. Neuroimmunol. 55 1994 99 106
22. A. Khoruts, S.D. Miller, and M.K. Jenkins Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells J. Immunol. 155 1995 5011 5017
23. B.C. Kieseier, R. Kiefer, J.M. Clements, K. Miller, G.M. Wells, T. Schweitzer, A.J. Gearing, and H.P. Hartung Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis Brain 121 Pt 1 1998 159 166
24. E. Layseca-Espinosa, L. Baranda, B. Alvarado-Sanchez, D. Portales-Perez, H. Portillo-Salazar, and R. Gonzalez-Amaro Rolipram inhibits polarization and migration of human T lymphocytes J. Invest. Dermatol. 121 2003 81 87
25. M.A. Lee, J. Palace, G. Stabler, J. Ford, A. Gearing, and K. Miller Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study Brain 122 Pt 2 1999 191 197
26. D. Leppert, E. Waubant, R. Galardy, N.W. Bunnett, and S.L. Hauser T cell gelatinases mediate basement membrane transmigration in vitro J. Immunol. 154 1995 4379 4389
27. R. Lichtinghagen, T. Seifert, A. Kracke, S. Marckmann, U. Wurster, and F. Heidenreich Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis J. Neuroimmunol. 99 1999 19 26
28. G.P. Livi, P. Kmetz, M.M. McHale, L.B. Cieslinski, G.M. Sathe, D.P. Taylor, R.L. Davis, T.J. Torphy, and J.M. Balcarek Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase Mol. Cell. Biol. 10 1990 2678 2686
29. I. Martinez, C. Puerta, C. Redondo, and A. Garcia-Merino Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase J. Neurol. Sci. 164 1999 13 23
30. C. Munaut, T. Salonurmi, S. Kontusaari, P. Reponen, T. Morita, J.M. Foidart, and K. Tryggvason Murine matrix metalloproteinase 9 gene. 5′-upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice J. Biol. Chem. 274 1999 5588 5596
31. J. Navarro, C. Punzon, J.L. Jimenez, E. Fernandez-Cruz, A. Pizarro, M. Fresno, and M.A. Munoz-Fernandez Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT J. Virol. 72 1998 4712 4720
32. G. Opdenakker, P.E. Van den Steen, and J. Van Damme Gelatinase B: a tuner and amplifier of immune functions Trends Immunol. 22 2001 571 579
33. K. Pahan, and M. Schmid Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis Neurosci. Lett. 287 2000 17 20
34. C. Puerta, I. Martinez, P. Baranda, M.R. Blasco, R. Castejon, J.A. Vargas, and A. Garcia-Merino Aminoguanidine reduces apoptosis of circulating V Beta 8.2 T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recovery J. Neuroimmunol. 110 2000 140 150
35. H. Sato, and M. Seiki Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells Oncogene 8 1993 395 405
36. N. Sommer, P.A. Loschmann, G.H. Northoff, M. Weller, A. Steinbrecher, J.P. Steinbach, R. Lichtenfels, R. Meyermann, A. Riethmuller, and A. Fontana The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis Nat. Med. 1 1995 244 248
37. E. Waubant, D.E. Goodkin, L. Gee, P. Bacchetti, R. Sloan, T. Stewart, P.B. Andersson, G. Stabler, and K. Miller Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis Neurology 53 1999 1397 1401
38. B. Xie, Z. Dong, and I.J. Fidler Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages J. Immunol. 152 1994 3637 3644
39. C. Yan, H. Wang, B. Aggarwal, and D.D. Boyd A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression FASEB J. 18 2004 540 541